72.11.Z - Scientific research and development activities
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -1,6 | -3,7 | -129,8 |
EBITDA | 0,7 | 0,2 | -1,5 | -963,7 |
Short time liabilities | 1,7 | 2,2 | 1,8 | -17,3 |
Equity capital | 14,2 | 12,6 | 9,2 | -27,3 |
Operating profit (EBIT) | -0,2 | -1,6 | -3,5 | -120,3 |
Assets | 16,8 | 16,4 | 15 | -8,5 |
Net profit (loss) | -0,2 | -1,6 | -3,4 | -116,4 |
Cash | 0,1 | 0,5 | 0 | -99 |
Liabilities and provisions for liabilities | 2,6 | 3,8 | 5,8 | 54,3 |
Net income from sale | 3,3 | 4,3 | 0,8 | -82,3 |
Working assets | 2,1 | 2,3 | 2,5 | 11,4 |
Depreciation | 1 | 1,7 | 2 | 13,7 |
% | % | % | p.p. | |
Profitability of capital | -1,5 | -12,6 | -37,5 | -24,9 |
Equity capital to total assets | 84,7 | 77,1 | 61,3 | -15,8 |
Gross profit margin | -6,5 | -37,4 | -486,4 | -449 |
EBITDA Margin | 22 | 4 | -197,7 | -201,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 185 | 191 | 896 | 705 |
Current financial liquidity indicator | 0.6909023523330688 | 0.6342024803161621 | -0,1 | |
Net dept to EBITDA | 1.0324392318725586 | -0.9430402517318726 | -1,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane